NCCN Guidelines Insights: Melanoma, Version 3.2016

J Natl Compr Canc Netw. 2016 Aug;14(8):945-58. doi: 10.6004/jnccn.2016.0101.

Abstract

The NCCN Guidelines for Melanoma have been significantly revised over the past few years in response to emerging data on a number of novel agents and treatment regimens. These NCCN Guidelines Insights summarize the data and rationale supporting extensive changes to the recommendations for systemic therapy in patients with metastatic or unresectable melanoma.

Publication types

  • Practice Guideline

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Combined Modality Therapy
  • Humans
  • Immunotherapy
  • Melanoma / diagnosis*
  • Melanoma / etiology
  • Melanoma / therapy*
  • Molecular Targeted Therapy
  • Neoplasm Staging
  • Retreatment
  • Treatment Outcome

Substances

  • Antineoplastic Agents